Skip to content
healthcare.dev
Get a free key

Talzenna

NDC 63539-025, talazoparib, capsule, liquid filled, from U.S. Pharmaceuticals.

Product NDC
63539-025
Status
Listed
Labeler
U.S. Pharmaceuticals
Dosage form
CAPSULE, LIQUID FILLED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217439
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63539-025 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TALAZOPARIB TOSYLATE.5 mg/1

Pharmacologic classes

Poly(ADP-Ribose) Polymerase Inhibitor [EPC]; Poly(ADP-Ribose) Polymerase Inhibitors [MoA]

Package NDCNDC-11Package
63539-025-306353900253030 CAPSULE, LIQUID FILLED in 1 BOTTLE (63539-025-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b653221e-971f-4452-92d4-797924f1ff59

Use it

Look up 63539-025 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63539-025 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63539-025. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.